ELLEN BALL: Open Payments
NPI 1669933461 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$826 in 34 payments from 10 companies in 2025. Trend: 2023 $244 · 2024 $0 · 2025 $826
Food & beverage: $636Education: $190
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $309 |
| Sumitomo Pharma America, Inc. | 9 | $146 |
| Antares Pharma, Inc. | 4 | $83 |
| IMMUNITYBIO, INC. | 3 | $69 |
| Endo USA, Inc. | 3 | $60 |
| Laborie Medical Technologies Corp. | 1 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| 180 Medical, Inc. | 1 | $23 |
| Procept Biorobotics Corporation | 1 | $22 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $18 |
Products named: ERLEADA, GEMTESA, XYOSTED, ANKTIVA, XIAFLEX, Nubeqa, ORGOVYX, GENTLECATH.
Industry payments across AL — which companies pay providers there.
